Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Looking forward, IMARC Group expects the market to reach a value of US$ 4.10 Billion by 2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient’s life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market report, along with forecasts for growth at the global and regional level from 2021-2026. Our report has categorized the market based on treatment type, allergy type, and distribution channel.

Breakup by Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)
     

Breakup by Allergy Type:

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others
     

Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
     

Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Treatment Type, Allergy Type, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Allergy Immunotherapies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Treatment Type
    5.5    Market Breakup by Allergy Type
    5.6    Market Breakup by Distribution Channel
    5.7    Market Breakup by Region
    5.8    Market Forecast
6    Market Breakup by Treatment Type
    6.1    Subcutaneous Immunotherapy (SCIT) 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Sublingual Immunotherapy (SLIT) 
        6.2.1    Market Trends
        6.2.2    Market Forecast
7    Market Breakup by Allergy Type
    7.1    Allergic Rhinitis
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Asthma
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Food Allergy
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Venom Allergy
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Others
        7.5.1    Market Trends
        7.5.2    Market Forecast
8    Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Retail Pharmacy 
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Online Pharmacy
        8.3.1    Market Trends
        8.3.2    Market Forecast
9    Market Breakup by Region
    9.1    Europe
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    North America
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Asia Pacific
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
    13.1    Price Indicators
    13.2    Price Structure
    13.3    Margin Analysis
14    Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    ALK-Abello A/S
        14.3.2    Allergy Therapeutics
        14.3.3    Stallergenes Greer
        14.3.4    HAL Allergy Group
        14.3.5    DBV Technologies
        14.3.6    Merck Group 
        14.3.7    Aimmune Therapeutics
        14.3.8    Circassia Pharmaceuticals 
        14.3.9    Anergis SA 
        14.3.10      Biomay AG 

List of Figures

Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion US$), 2015 - 2020
Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2020
Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2020
Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2020
Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2020
Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
Figure 10: Global: Allergy Immunotherapies Industry: Porter’s Five Forces Analysis
Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million US$), 2015 & 2020
Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million US$), 2021-2026
Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million US$), 2015 & 2020
Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million US$), 2021-2026
Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million US$), 2015 & 2020
Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million US$), 2021-2026
Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million US$), 2021-2026
Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Allergy Immunotherapies Market Structure
Table 7: Global: Allergy Immunotherapies Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

The global allergy immunotherapies market was valued at US$ 2.3 Billion in 2020. 

The rising prevalence of several allergies based on environmental and lifestyle-based factors, along with the growing consumer awareness towards numerous health benefits of allergy immunotherapies represent some of the factors catalyzing the global allergy immunotherapies market. 

Sudden outbreak of the COVID-19 pandemic has led to the rising adoption of allergy immunotherapies in extensive R&D activities for analyzing the reaction of novel COVID-19 vaccines, thereby augmenting the market growth.

Based on the treatment type, the global allergy immunotherapies market can be segmented into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Currently, subcutaneous immunotherapy (SCIT) holds the majority of the total market share.

Based on the allergy type, the global allergy immunotherapies market has been segregated into allergic rhinitis, asthma, food allergy, venom allergy, and others, where allergic rhinitis currently represents the largest segment.

Based on the distribution channel, the global allergy immunotherapies market can be divided into hospital pharmacy, retail pharmacy, and online pharmacy. Amongst these, hospital pharmacy accounts for the majority of the total market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.

Some of the major players in the global allergy immunotherapies market include ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Group, DBV Technologies, Merck Group, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, Biomay AG, etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links